or
forgot password
  • cancer clinical trials in portsmouth, NH

  • Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Estrogen Receptor-positive Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Pemetrexed and Best Supportive Care Versus Placebo and Best Supportive Care in Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Portsmouth, New Hampshire 03801
    Non Small Cell Lung Cancer
    Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Adenocarcinoma of the Colon, Stage II Colon Cancer
    Enzastaurin Versus Lomustine in Glioblastoma
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Portsmouth, New Hampshire 03801
    Glioblastoma
    Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Estrogen Receptor-positive Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIB Breast Cancer
    Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-Small Lung Cancer That Was Removed By Surgery
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Stage IB Non-small Cell Lung Cancer, Stage IIA Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer
    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    HER2-positive Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer
    First-Line Chemotherapy and Trastuzumab With or Without Bevacizumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER-2/NEU
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    HER2-positive Breast Cancer, Male Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Carboplatin, Docetaxel, Bevacizumab, and Erlotinib Versus Chemotherapy Alone in Resected NSCLC
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Non-Small Cell Lung Cancer
    Phase I/II Trial of Sorafenib Plus Ixabepilone in HER2-Negative Metastatic Breast Cancer
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Metastatic Breast Cancer
    Preoperative Pemetrexed and Carboplatin for Select Stage IB, II, and III Non-Squamous Non-Small-Cell Lung Cancer
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Non Small Cell Lung Cancer
    Preoperative Chemotherapy and Bevacizumab in Patients With Stage IB (>4 cm), II, or Select Stage III NSCLC
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Non-Small Cell Lung Cancer
    Trial of Bendamustine, Bortezomib, and Rituximab in Patients With Previously Untreated Low Grade Lymphoma
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Lymphoma
    Trial of Amrubicin as Treatment for Patients With HER2-Negative Metastatic Breast Cancer
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Metastatic Breast Cancer
    Carboplatin, Pemetrexed, and Panitumumab in Patients With Advanced Non-Squamous K-ras Wild Type NSCLC
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Non-Small-Cell Lung Cancer
    Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    A Study of Chemotherapy and Ramucirumab vs. Chemotherapy Alone in Second Line Non-small Cell Lung Cancer Participants Who Received Prior First Line Platinum Based Chemotherapy
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Portsmouth, New Hampshire 03801
    Non Small Cell Lung Cancer
    A Study in Patients With Rheumatoid Arthritis
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Portsmouth, New Hampshire 03801
    Rheumatoid Arthritis
    FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Colorectal Cancer
    Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting
    Portsmouth Regional Hospital
    Portsmouth, New Hampshire 03802
    Chronic Myeloid Leukemia
    Study of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
    Portsmouth Regional Hospital Hematology/Oncology Clinic
    Portsmouth, New Hampshire 03801
    Tumor
    Study of LY2181308 in Combination With Docetaxel Versus Docetaxel in Patients With Non-Small Cell Lung Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
    Portsmouth, New Hampshire 03801
    Non Small Cell Lung Cancer